| MedWatch - The FDA Safety Information and Adverse Event Reporting Program On Tuesday, December 21, 2021, the Cybersecurity and Infrastructure Security Agency (CISA) published a vulnerability disclosure ICSMA-21-355-01 on the Fresenius Kabi Agilia Connect Infusion System. Successful remote exploitation of these vulnerabilities could allow an attacker to gain access to sensitive information, modify settings, or perform arbitrary actions as an unauthorized user. Affected components requiring a software security patch include: - Agilia Connect WiFi module of the pumps vD25 and prior
- Agilia Link+ v3.0 D15 and prior
- Vigilant Software Suite v1.0: Vigilant Centerium, Vigilant MasterMed and Vigilant Insight; and
- Agilia Partner maintenance software v3.3.0 and prior.
Questions? If you have questions about this cybersecurity alert, contact cybermed@fda.hhs.gov | | | |
No comments:
Post a Comment